These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 18725458

  • 1. Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response.
    Keserü B, Barbosa-Sicard E, Popp R, Fisslthaler B, Dietrich A, Gudermann T, Hammock BD, Falck JR, Weissmann N, Busse R, Fleming I.
    FASEB J; 2008 Dec; 22(12):4306-15. PubMed ID: 18725458
    [Abstract] [Full Text] [Related]

  • 2. EETs promote hypoxic pulmonary vasoconstriction via constrictor prostanoids.
    Kandhi S, Zhang B, Froogh G, Qin J, Alruwaili N, Le Y, Yang YM, Hwang SH, Hammock BD, Wolin MS, Huang A, Sun D.
    Am J Physiol Lung Cell Mol Physiol; 2017 Aug 01; 313(2):L350-L359. PubMed ID: 28450284
    [Abstract] [Full Text] [Related]

  • 3. Cytochrome P450 epoxygenase-derived 5,6-epoxyeicosatrienoic acid relaxes pulmonary arteries in normoxia but promotes sustained pulmonary vasoconstriction in hypoxia.
    Strielkov I, Krause NC, Knoepp F, Alebrahimdehkordi N, Pak O, Garcia C, Ghofrani HA, Schermuly RT, Seeger W, Grimminger F, Sommer N, Weissmann N.
    Acta Physiol (Oxf); 2020 Sep 01; 230(1):e13521. PubMed ID: 32506676
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cytochrome P450 Epoxygenase-Dependent Activation of TRPV4 Channel Participates in Enhanced Serotonin-Induced Pulmonary Vasoconstriction in Chronic Hypoxic Pulmonary Hypertension.
    Xia Y, Xia L, Jin Z, Jin R, Paudel O, Sham JSK.
    Anal Cell Pathol (Amst); 2020 Sep 01; 2020():8927381. PubMed ID: 32399392
    [Abstract] [Full Text] [Related]

  • 8. Soluble epoxide hydrolase deficiency or inhibition enhances murine hypoxic pulmonary vasoconstriction after lipopolysaccharide challenge.
    Wepler M, Beloiartsev A, Buswell MD, Panigrahy D, Malhotra R, Buys ES, Radermacher P, Ichinose F, Bloch DB, Zapol WM.
    Am J Physiol Lung Cell Mol Physiol; 2016 Dec 01; 311(6):L1213-L1221. PubMed ID: 27815261
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia.
    Zhang W, Otsuka T, Sugo N, Ardeshiri A, Alhadid YK, Iliff JJ, DeBarber AE, Koop DR, Alkayed NJ.
    Stroke; 2008 Jul 01; 39(7):2073-8. PubMed ID: 18369166
    [Abstract] [Full Text] [Related]

  • 11. Cytochrome P450-derived epoxyeicosatrienoic acids and pulmonary hypertension: central role of transient receptor potential C6 channels.
    Loot AE, Fleming I.
    J Cardiovasc Pharmacol; 2011 Feb 01; 57(2):140-7. PubMed ID: 20588188
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A soluble epoxide hydrolase inhibitor--8-HUDE increases pulmonary vasoconstriction through inhibition of K(ATP) channels.
    Liu Y, Zhang J, Yu L, Cao F, Rao J, Li J, Jiang C, Falck JR, Jacobs ER, Zhu D.
    Pulm Pharmacol Ther; 2012 Feb 01; 25(1):69-76. PubMed ID: 22155000
    [Abstract] [Full Text] [Related]

  • 15. Epoxyeicosatrienoic acids regulate Trp channel dependent Ca2+ signaling and hyperpolarization in endothelial cells.
    Fleming I, Rueben A, Popp R, Fisslthaler B, Schrodt S, Sander A, Haendeler J, Falck JR, Morisseau C, Hammock BD, Busse R.
    Arterioscler Thromb Vasc Biol; 2007 Dec 01; 27(12):2612-8. PubMed ID: 17872452
    [Abstract] [Full Text] [Related]

  • 16. Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart.
    Gross GJ, Gauthier KM, Moore J, Falck JR, Hammock BD, Campbell WB, Nithipatikom K.
    Am J Physiol Heart Circ Physiol; 2008 Jun 01; 294(6):H2838-44. PubMed ID: 18441205
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction.
    Tabeling C, Yu H, Wang L, Ranke H, Goldenberg NM, Zabini D, Noe E, Krauszman A, Gutbier B, Yin J, Schaefer M, Arenz C, Hocke AC, Suttorp N, Proia RL, Witzenrath M, Kuebler WM.
    Proc Natl Acad Sci U S A; 2015 Mar 31; 112(13):E1614-23. PubMed ID: 25829545
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.